News

Food and Drug Administration Commissioner Marty Makary committed to reviewing the abortion drug mifepristone in a letter sent to Senator Josh Hawley (R-Mo.).   “As with all drugs, FDA continues to ...
Food and Drug Administration Commissioner Marty Makary said he plans to review the safety of abortion drug mifepristone after ...
This week saw actions from President Donald Trump and the executive branch designed to implement the administration s ...
The Food and Drug Administration commissioner has committed to reviewing the abortion drug mifepristone after previously ...
The head of the Food and Drug Administration has vowed to conduct a review of the abortion pill as the drug continues to be ...
A recent study found that 11 percent of women experience an adverse effect from mifepristone, 22 times higher than its current label indicates.
California and three other states have called on the FDA to ease restrictions on the abortion pill mifepristone, which they ...
Mo., had a heated exchange with a liberal law professor over the spike in nationwide injunctions against Trump's executive orders.
Josh Hawley, R-Mo., Makary revealed the FDA's ... "As the Commissioner of Food and Drugs, I am committed to conducting a review of mifepristone and working with the professional career scientists ...
Elon Musk’s Opposition to Domestic Policy Bill Presents New Challenges for GOP Leadership Judge Blocks Immediate Deportation of Family of Suspect in Boulder Firebombing Attack Columbia ...